---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-027281"
form_type: "8-K"
ticker: "ADTX"
cik: "0001726711"
company_name: "Aditxt, Inc."
filed_at: "2026-03-13T23:59:59+00:00"
generated_at: "2026-05-15T12:38:13.622667+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Aditxt acquires Ignite Proteomics for $36M in preferred stock; issues $3.2M notes

## Summary
- Acquired 100% of Ignite Proteomics for 36,000 Series A-2 Convertible Preferred Shares (stated value $36M).
- Ignite's RPPA platform measures protein expression for therapy selection; CLIA lab, Medicare PLA ~$2,200/test.
- Closed $3.2M note purchase (10% OID) with $2.875M funding; 6% interest, 9-month maturity, prepayable.
- Company believes it regained compliance with Nasdaq minimum stockholders' equity requirement ($2.5M) after acquisition.
- Ignite plans to launch program in 2026 targeting >600,000 US metastatic cancer patients.

## SEC filing metadata
- accession: 0001213900-26-027281
- form_type: 8-K
- ticker: ADTX
- cik: 0001726711
- company_name: Aditxt, Inc.
- filed_at: 2026-03-13T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 5.03, 2.01, 2.03, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1726711/000121390026027281/0001213900-26-027281-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1726711/000121390026027281/ea0279443-8k_aditxt.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-027281
- JSON: https://secwatch.observer/filing/0001213900-26-027281.json
- Plain text: https://secwatch.observer/filing/0001213900-26-027281.txt

## Key facts
- Debt Financings
  Aditxt, Inc. incurred loan of aggregate principal amount of $3,194,444.44 with several buyers listed on the issuance schedule attached thereto at 6% per annum maturing nine months from the issuance date.
  - Instrument: loan
  - Principal: aggregate principal amount of $3,194,444.44
  - Counterparty: several buyers listed on the issuance schedule attached thereto
  - Rate: 6% per annum
  - Maturity: nine months from the issuance date
  - Event: incurrence
  source text: On March 11, 2026, the Company entered into a Note Purchase Agreement (the “Note Purchase Agreement”) with the several buyers listed on the issuance schedule attached thereto (the “Note Buyers”), pursuant to which the Company will issue its 10% original issue discount promissory notes (the “Notes”) for the aggregate principal amount of $3,194,444.44.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1726711/000121390026027281/0001213900-26-027281-index.htm
- Governance Changes
  Aditxt, Inc.: Filed Certificate of Designations creating Series A-2 Convertible Preferred Stock (effective 2026-03-10).
  - Change: charter amendment
  - Effective: 2026-03-10
  source text: On March 10, 2026, the Company filed the Certificate of Designations with the Delaware Secretary of State designating, 36,000 shares of its authorized and unissued Preferred Shares as Series A-2 Convertible Preferred Shares (the “Preferred Shares”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1726711/000121390026027281/0001213900-26-027281-index.htm
- M&A Transactions
  Aditxt, Inc. completed an acquisition involving IMAC Holdings, Inc. for 36,000 shares of the Company’s newly created Series A-2 Convertible Preferred Stock (closed 2026-03-11).
  - Action: acquisition
  - Counterparty: IMAC Holdings, Inc.
  - Consideration: 36,000 shares of the Company’s newly created Series A-2 Convertible Preferred Stock
  - Closing: 2026-03-11
  source text: Agreement ”) with IMAC Holdings, Inc. (“ IMAC ”) and the several investors listed on the Schedule of Buyers attached to the Agreement (collectively, the “Buyers”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1726711/000121390026027281/0001213900-26-027281-index.htm
- Material Agreements
  Aditxt, Inc. entered into Securities Purchase Agreement with IMAC Holdings, Inc. valued at 36,000 shares of Series A-2 Convertible Preferred Stock ($36,000,000 total stated value) for 100% eq (effective 2026-03-11).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: IMAC Holdings, Inc.
  - Value: 36,000 shares of Series A-2 Convertible Preferred Stock ($36,000,000 total stated value) for 100% eq
  - Effective: 2026-03-11
  source text: On March 11, 2026, Aditxt, Inc. (the " Company ") entered into a Securities Purchase Agreement (the " Agreement ") with IMAC Holdings, Inc. (" IMAC ") and the several investors listed on the Schedule of Buyers attached to the Agreement (collectively, the "Buyers") whereby the Buyers sold 100% of their equity interests in Ignite Proteomics, LLC, a Delaware limited liability company (" Ignite ") and formerly a wholly owned subsidiary of IMAC plus $475,000 in cash, for a total consideration of 36,000 shares of the Company's newly created Series A-2 Convertible Preferred Stock (the " Preferred Shares ").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1726711/000121390026027281/0001213900-26-027281-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.